Table 4.

Clinical risk assessment scores for overall population, and stratified by MELD (median, IQR)

	Total	Lab MELD < 30	Lab MELD ≥ 30
	(N=289)	(n=131)	(n=158)	p-value
MELD	31.6 (17.4, 38.6)	14.7 (8.8, 22.6)	37.7 (34.2, 41.2)	<0.001
MELD-Na	32.6 (17.5, 38.6)	15.6 (8.8, 24.2)	37.7 (34.4, 41.1)	<0.001
MELD 3.0	32.4 (18.1, 38.3)	16.6 (9.8, 24.8)	37.5 (34.3, 41.1)	<0.001
D-MELD	841.2 (545.6, 1219.9)	543.5 (321.9, 795.8)	1108.9 (836.2, 1496.0)	<0.001
MELD-GRAIL	28.4 (23.1, 30.5)	22.5 (19.8, 25.4)	30.3 (29.1, 31.4)	<0.001
MELD-GRAIL-Na	28.3 (23.2, 30.3)	22.6 (20.0, 25.5)	30.2 (28.9, 31.2)	<0.001
UCLA-FRS	16.5 (10.0, 20.5)	9.5 (4.5, 12.5)	20.3 (18.0, 23.0)	<0.001
BAR	13.0 (6.0, 17.0)	5.0 (3.0, 9.0)	16.0 (14.0, 18.0)	<0.001
SOFT	14.0 (7.0, 25.0)	7.0 (5.0, 13.0)	22.5 (13.0, 29.0)	<0.001
P-SOFT	13.0 (7.0, 26.0)	8.0 (5.0, 11.0)	23.0 (14.0, 28.0)	<0.001
LDRI	1.2 (1.1, 1.5)	1.3 (1.1, 1.6)	1.2 (1.1, 1.4)	0.02
LIFI	33.2 (22.3, 45.9)	38.3 (21.6, 48.4)	31.3 (23.0, 44.3)	0.32
Low (<46)	1 (0.3)	0 (0.0)	1 (0.6)	<0.001
Moderate (46–79)	7 (2.4)	0 (0.0)	7 (4.4)	<0.001
High (≥80)	116 (40.1)	18 (13.7)	98 (62.0)	<0.001

IQR, interquartile range; MELD, Model for End-Stage Liver Disease; GRAIL, GFR assessment in liver disease; UCLA-FRS, University of California Los Angeles Futility Risk Score; BAR, balance of risk; SOFT, survival outcomes following liver transplantation; P-SOFT, predicted survival outcomes following liver transplantation;